Demographics, Treatment Patterns, Safety, and Real-World Effectiveness in Patients ≥70 Years of Age with Chronic Lymphocytic Leukemia Receiving Bendamustine with or without Rituximab

被引:0
|
作者
Kolibaba, Kathryn S. [1 ]
Joshi, Avani D. [2 ]
Sterchele, James A. [3 ]
Forsyth, Michael [2 ]
Alwon, Erin [2 ]
Beygi, Hooman [3 ]
Kennealey, Gerard T. [3 ]
机构
[1] NW Canc Specialists, Vancouver, WA USA
[2] US Oncol, The Woodlands, TX USA
[3] Cephalon Inc, Frazer, PA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1674 / 1674
页数:1
相关论文
共 50 条
  • [21] Real-World Efficacy and Safety of Venetoclax Alone and in Combination with Rituximab in Patients with Chronic Lymphocytic Leukemia: Interim Results of the Verone Study
    Ysebaert, Loic
    Troussard, Xavier
    Levy, Vincent
    Le Calloch, Ronan
    Guieze, Romain
    Laribi, Kamel
    Lepretre, Stephane
    Michallet, Anne-Sophie
    Leblond, Veronique
    Feugier, Pierre
    Lahjibi, Elhem
    Ramier, Julien
    Delmer, Alain
    BLOOD, 2022, 140 : 12395 - 12396
  • [22] TREATMENT AND PROGNOSTIC TESTING PATTERNS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: THE INFORMCLL™ REAL-WORLD REGISTRY INTERIM ANALYSIS
    Sundaram, M.
    Ghosh, N.
    Kadish, K.
    Upasani, S.
    Han, J.
    Amaya-Chanaga, C.
    Iyengar, R.
    VALUE IN HEALTH, 2020, 23 : S89 - S89
  • [23] Treatment and prognostic testing patterns in patients with chronic lymphocytic leukemia: updates from the informCLL™ real-world registry
    Ghosh, Nilanjan
    Mato, Anthony
    Barrientos, Jacqueline
    Brander, Danielle
    Pagel, John
    Gutierrez, Meghan
    Kadish, Karen
    Tomlinson, Brian
    Upasani, Sandhya
    Sundaram, Murali
    Han, Jennifer
    Amaya-Chanaga, Carlos
    Iyengar, Reethi
    Sharman, Jeff
    LEUKEMIA & LYMPHOMA, 2020, 61 : 31 - 33
  • [24] A Real-World Evidence Study of the Temporal Evolution in Treatment Patterns and Outcomes for Chronic Lymphocytic Leukemia
    Cheung, Winson Y.
    Boyne, Devon J.
    Jarada, Tamer N.
    Carbonell, Chantelle
    Owen, Carolyn
    BLOOD, 2023, 142
  • [25] Process mining for exploring treatment patterns in chronic lymphocytic leukemia in a real-world oncology database
    Black, James A.
    Castro, Felipe
    Lundberg, Linda
    Marino, Michael
    Niks, Rudi
    Rozinat, Anne
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 66 - 66
  • [26] REAL-WORLD EFFECTIVENESS AND TREATMENT PATTERNS OF VENETOCLAX-BASED REGIMENS AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED IN COMMUNITY SETTINGS
    Zakeri, M.
    Emechebe, N.
    Chowdhery, R.
    Jawaid, D.
    Alhasani, H.
    Manzoor, B. S.
    VALUE IN HEALTH, 2023, 26 (06) : S54 - S55
  • [27] Treatment sequencing and outcomes in patients with chronic lymphocytic leukemia: the informCLL™ real-world registry
    Mato, Anthony
    Ghosh, Nilanjan
    Barrientos, Jacqueline
    Brander, Danielle
    Pagel, John
    Gutierrez, Meghan
    Kadish, Karen
    Tomlinson, Brian
    Ipe, David
    Sundaram, Murali
    Han, Jennifer
    Amaya-Chanaga, Carlos
    Iyengar, Reethi
    Sharman, Jeff
    LEUKEMIA & LYMPHOMA, 2020, 61 : 33 - 36
  • [28] Real-World Healthcare Resource Utilization in Patients with Chronic Lymphocytic Lymphoma: Differences between Patients Treated with Ibrutinib or Bendamustine plus Rituximab
    Irwin, Debra
    Zhang, Lu
    Wilson, Kathleen
    Hoehn, Gerard
    Szabo, Erika
    Tang, Boxiong
    BLOOD, 2018, 132
  • [29] Real-world healthcare resource utilization and costs in patients with chronic lymphocytic leukemia: differences between patients treated with first-line ibrutinib or bendamustine plus rituximab
    Irwin, Debra
    Wilson, Kathleen
    Thompson, Stephen
    Choudhry, Azhar
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (04) : 623 - 628
  • [30] Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab
    Spacek, Martin
    Obrtlikova, Petra
    Hrobkova, Stanislava
    Cmunt, Eduard
    Karban, Josef
    Molinsky, Jan
    Simkovic, Martin
    Mocikova, Heidi
    Mohammadova, Lekaa
    Panovska, Anna
    Novak, Jan
    Trneny, Marek
    Smolej, Lukas
    Doubek, Michael
    LEUKEMIA RESEARCH, 2019, 79 : 17 - 21